Forecast: Top 15 Pharma Companies in 2018

Novartis will be No. 1, and just one U.S. firm will be in the top 5

By Christopher Freeburn, InvestorPlace Writer Apr 26, 2012, 4:22 pm EDT

Life-science sector research firm EvaluatePharma has analyzed worldwide sales figures and trends for leading pharmaceutical companies and projects that by 2018, Novartis (NYSE:NVS) will become the world’s largest prescription drug manufacturer.

By then, only one American drugmaker, Pfizer (NYSE:PFE), will remain in the top 5, according to EvaluatePharma.

Here are the firm’s Top 15 Pharmaceutical manufactures in 2018:

  1. Novartis
  2. Sanofi (NYSE:SNY)
  3. Pfizer
  4. GlaxoSmithKline (NYSE:GSK)
  5. Roche (PINK:RHHBY)
  6. Merck & Co. (NYSE:MRK)
  7. Johnson & Johnson (NYSE:JNJ)
  8. Teva (NASDAQ:TEVA)
  9. AstraZeneca (NYSE:AZN)
  10. Abbott Laboratories (NYSE:ABT)
  11. Bristol-Myers Squibb (NYSE:BMY)
  12. Nordisk (NYSE:NVO)
  13. Takeda (PINK:TKPYY)
  14. Bayer (PINK:BAYRY)
  15. Gilead Sciences (NASDAQ:GILD)

For EvaluatePharma’s complete list and data, click here.

Article printed from InvestorPlace Media, https://investorplace.com/2012/04/forecast-top-15-pharma-companies-in-2018/.

©2021 InvestorPlace Media, LLC